The myeloid cell type I IFN system promotes antitumor immunity over pro-tumoral inflammation in cancer T-cell therapy.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationCancers
View this publicationOncogenesis
View this publicationImmunity
View this publicationNature immunology
View this publicationFrontiers in oncology
View this publicationImmunity
View this publicationTranslational oncology
View this publicationPublication categories: Top publication
Immunity
View this publicationPublication categories: Top publication
Immunity
View this publication